CATHERINE SMITH: Open Payments
NPI 1023608072 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,221 in 59 payments from 12 companies in 2025. Trend: 2023 $714 · 2024 $611 · 2025 $1,221
Food & beverage: $1,221
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 14 | $263 |
| Corium, LLC | 11 | $253 |
| Neos Therapeutics, LP | 7 | $117 |
| Supernus Pharmaceuticals, Inc. | 5 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $106 |
| Tempus AI, Inc | 4 | $89 |
| Alkermes, Inc. | 4 | $79 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Tris Pharma Inc | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
Products named: Jornay PM, Azstarys, Qelbree, CAPLYTA, TEMPUS PIXEL, Adzenys XR-ODT, Onyda XR, ARISTADA.
Industry payments across TX — which companies pay providers there.
